Avinger up on start of new artery treatment study

Enrollment is underway in a post-marketing trial, IMAGE-BTK, evaluating Avinger’s (NASDAQ:AVGR) Pantheris SV image-guided atherectomy system for the treatment of peripheral artery lesions below-the-knee (BTK).

The primary endpoint of the 60-subject study is the reduction in residual stenosis in target lesions on a standalone basis.

The company launched the device in the U.S. in Q3 2019.

https://seekingalpha.com/news/3533909-avinger-up-4-premarket-on-start-of-new-pantheris-study